RealTime HIV-1
Device
Abbott Laboratories
Total Payments
$827,527
Transactions
90
Doctors
13
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $1,401 | 6 | 3 |
| 2019 | $32.13 | 2 | 2 |
| 2017 | $826,094 | 82 | 9 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $502,943 | 28 | 60.8% |
| Education | $301,962 | 38 | 36.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,115 | 6 | 1.6% |
| Consulting Fee | $6,850 | 2 | 0.8% |
| Travel and Lodging | $2,159 | 4 | 0.3% |
| Food and Beverage | $498.80 | 12 | 0.1% |
Payments by Type
Research
$502,943
28 transactions
General
$324,584
62 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Abbott RealTime IDH1 (08N90) Initial Development Mutation Detection Clinical Testinq Protocol | Abbott Laboratories | $116,159 | 0 |
| Workflow Analysis and Performance evaluation studies for Abbott Realtime IDH1/2 assay | Abbott Laboratories | $111,335 | 0 |
| Abbott RealTime IDH1&IDH2 CDx Reproductibility Studies (the "Protocols") | Abbott Laboratories | $95,030 | 0 |
| A clinical retrospective trial to evaluate the reproducibility of the Vysis MET CDx Fluorescence in-situ Hybridization (FISH) Kit assay in formalin-fixed, paraffin-embedded non small cell lung cancer (NSCLC) specimens | Abbott Laboratories | $51,944 | 0 |
| Using a novel laboratory standard to determine the true costs of false positive HIV blips | Abbott Laboratories | $50,000 | 0 |
| Vysis DNA FISH Probes manufactured by Abbott Molecular Inc. tested by Institution per Abbott Molecular FISH Probe Study Plan Protocol. | Abbott Laboratories | $42,475 | 0 |
| Cytomegalovirus viremia in critically ill patients with SLE: a risk factor for poor outcomes | Abbott Laboratories | $25,000 | 0 |
| Workflow analysis and performance evaluation studies for Abbott IDH1/2 real-time assay | Abbott Laboratories | $11,000 | 0 |
Top Doctors Receiving Payments for RealTime HIV-1
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Oakland, CA | $818,019 | 72 |
| , M.D | Infectious Disease | Stanford, CA | $6,400 | 1 |
| , M.D | Allergy & Immunology | Silver Spring, MD | $1,361 | 4 |
| Alison Cushman Vokoun | Molecular Genetic Pathology | Omaha, NE | $821.08 | 1 |
| , M.D | Anatomic Pathology & Clinical Pathology | Charlottesville, VA | $450.00 | 1 |
| , MD | Otolaryngology | Miami, FL | $186.17 | 1 |
| , M.D | Cytopathology | Rochester, MN | $117.62 | 3 |
| , MD | Pediatric Nephrology | Bronx, NY | $64.74 | 1 |
| , M.D | Anatomic Pathology & Clinical Pathology | Chicago, IL | $22.27 | 1 |
| , M.D., PHD | Anatomic Pathology & Clinical Pathology | New York, NY | $20.07 | 1 |
| , MD | Anatomic Pathology & Clinical Pathology | Fresh Meadows, NY | $20.07 | 1 |
| , M.D | Hematology | Sioux Falls, SD | $17.66 | 1 |
| , M.D | Anatomic Pathology & Clinical Pathology | Charleston, SC | $15.78 | 1 |
| , BACHELOR OF MEDICINE | Anatomic Pathology & Clinical Pathology | New Orleans, LA | $11.74 | 1 |
Ad
Manufacturing Companies
- Abbott Laboratories $827,527
Product Information
- Type Device
- Total Payments $827,527
- Total Doctors 13
- Transactions 90
About RealTime HIV-1
RealTime HIV-1 is a device associated with $827,527 in payments to 13 healthcare providers, recorded across 90 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2017 to 2021. In 2021, $1,401 was paid across 6 transactions to 3 doctors.
The most common payment nature for RealTime HIV-1 is "Unspecified" ($502,943, 60.8% of total).
RealTime HIV-1 is associated with 8 research studies, including "Abbott RealTime IDH1 (08N90) Initial Development Mutation Detection Clinical Testinq Protocol" ($116,159).